Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Post by Bucknelly21on Aug 21, 2023 2:36pm
91 Views
Post# 35598358

Paul, phillipe, dawn

Paul, phillipe, dawn Somehow over that last 4 years or more they managed to completely erode any and all credibility they had left. I do tend to struggle with not voting people out in regards to the larger holders... I mean i get not wanting to throw a bump in the middle of the th1902 stuff but it honestly can get worse even with people being removed. As for paul I'm sure he would be good in the right situation but hes not right for this company and I think everyone knows it whether or not they want to admit it. Nothing he has been apart of from the start has panned out. In fact it's completely went the opposite direction. And per his words which is about tall he has people will be held accountable... id love to know where that has been during this dumpster fire he has created. As I've said before im no longer a shareholder but watch and follow still as I would love to get some redemption for all the money these guys have cost me. I hope it works out but they have no signs of doing anything different as usual. If you have so many assets and all this why is it that every other bio in Montreal seems to get buyouts and partnerships ect and thera doesn't even get mentioned. It's because they probably are stubborn in those talks as they have been this entire time dealing with the shareholders. They have no regard for anyone but themselves. Granting bonuses and options left and right every chance they can and leaving everyone else holding the bag. Glad I was able to convince myself " it wasn't coming" before I sold. If by some miracle they do decide to act in a manor that shows actions then I'll reconsider but I have seen nothing to suggest that 
<< Previous
Bullboard Posts
Next >>